NCT05833217
- Conditions
- COVID-19, Chronic Disease, Coronaviridae Infections, +22 more
- Locations
-
- Clinical and Translational Research Unit Palo Alto, California, United States
- Stanford Health Palo Alto, California, United States
Clinical trial condition
Explore clinical trials studying Insulin Resistance. Study availability and eligibility vary by location and protocol.
NCT05833217
NCT05165706
NCT06704321
NCT06419803
NCT06315725
NCT06419777
NCT06061926
NCT05760339
NCT02647827
NCT06597851